Vietnam to carry out clinical trials of France’s XAV-19 Covid-19 drug
XAV-19 is a coronavirus treatment drug based on polyclonal antibodies that targets Covis-19 patients with moderate conditions.
XAV-19 is a coronavirus treatment drug based on polyclonal antibodies that targets Covis-19 patients with moderate conditions.